Search Results

Filter
  • 1-10 of  479,803 results for ""UNITED States""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comprehensive Analysis of Clinical Studies and Regulations of Therapeutic Applications in the United States and Japan.

  • Authors : Ono M; Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, Waseda University, 2-2 Wakamatsucho, Shinjuku, Tokyo, 162-8480, Japan.; Iwasaki K

Subjects: United States Food and Drug Administration*; United States ; Japan

  • Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2023 Jan; Vol. 57 (1), pp. 86-99. Date of Electronic Publication: 2022 Sep 07.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Synthetic Approaches to the New Drugs Approved During 2022.

  • Authors : France SP; Process Research and Development, Merck & Co., Rahway, NJ 07065, United States.; Lindsey EA

Subjects: Drug Approval*; United States ; Japan

  • Source: Journal of medicinal chemistry [J Med Chem] 2024 Mar 28; Vol. 67 (6), pp. 4376-4418. Date of Electronic Publication: 2024 Mar 15.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531

Record details

×
Academic Journal

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.

  • Authors : Bennett CL; College of Pharmacy, University of South Carolina, Columbia, SC, USA; WJB Dorn VA Medical Center, Columbia, SC, USA

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/legislation & jurisprudence ; United States Food and Drug Administration*/United States Food and Drug Administration*/United States Food and Drug Administration*/legislation & jurisprudence; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use

  • Source: The Lancet. Oncology [Lancet Oncol] 2020 Dec; Vol. 21 (12), pp. e575-e588.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488

Record details

×
Academic Journal

Timing of Pediatric Drug Approval and Clinical Evidence Submitted to Regulatory Authorities: International Comparison Among Japan, the United States, and the European Union.

  • Authors : Hirota S; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.; Yamaguchi T

Subjects: Drug Approval* ; Drug Labeling* ; Off-Label Use*

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Nov; Vol. 108 (5), pp. 985-994. Date of Electronic Publication: 2020 Jan 25.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model:

Record details

×
Academic Journal

A critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinib.

  • Authors : Kidoguch K; Saga-Ken medical centre KOSEIKAN, Department of Hematology, Saga, Japan. .; Shibusawa M

Subjects: Benzothiazoles/Benzothiazoles/Benzothiazoles/*therapeutic use ; Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*organization & administration ; Drug Approval/Drug Approval/Drug Approval/*organization & administration

  • Source: Investigational new drugs [Invest New Drugs] 2021 Dec; Vol. 39 (6), pp. 1457-1459. Date of Electronic Publication: 2021 Jul 15.Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model:

Record details

×
Academic Journal

Shift Volume Directly Impacts Neuroradiology Error Rate at a Large Academic Medical Center: The Case for Volume Limits.

  • Authors : Ivanovic V; From the Department of Radiology, Section of Neuroradiology (V.I., J.F.H., R.B.), Medical College of Wisconsin, Milwaukee, Wisconsin .; Broadhead K

Subjects: Radiology*; Humans ; United States

  • Source: AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2024 Apr 08; Vol. 45 (4), pp. 374-378. Date of Electronic Publication: 2024 Apr 08.Publisher: American Society of Neuroradiology Country of Publication: United States NLM ID: 8003708

Record details

×
Academic Journal

Comparing factors related to perceived control and preventive behaviors from COVID-19 between Japanese and American nursing students: A cross-sectional study.

  • Authors : Kondo A; International Nursing Development, Tokyo Medical and Dental University, Tokyo, Japan.; Abuliezi R

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Students, Nursing*; Humans

  • Source: Japan journal of nursing science : JJNS [Jpn J Nurs Sci] 2024 Apr; Vol. 21 (2), pp. e12585. Date of Electronic Publication: 2024 Feb 01.Publisher: Wiley on behalf of the Japan Academy of Nursing Science Country of Publication: Japan NLM ID:

Record details

×
Academic Journal

Emotionally expressive interdependence in Latin America: Triangulating through a comparison of three cultural zones.

Subjects: Cross-Cultural Comparison* ; Emotions*/Emotions*/Emotions*/physiology; Humans

  • Source: Emotion (Washington, D.C.) [Emotion] 2024 Apr; Vol. 24 (3), pp. 820-835. Date of Electronic Publication: 2023 Oct 12.Publisher: American Psychological Association Country of Publication: United States NLM ID: 101125678

Record details

×
Academic Journal

Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan.

  • Authors : Takaya R; Graduate School of Public Health, St. Luke's International University, 10-1 Akashi-Cho, Chuo-City, Tokyo, 104-0044, Japan. .; Mori N

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Pneumonia, Bacterial*/Pneumonia, Bacterial*/Pneumonia, Bacterial*/drug therapy ; Cephalosporins*

  • Source: BMC health services research [BMC Health Serv Res] 2024 Mar 28; Vol. 24 (1), pp. 389. Date of Electronic Publication: 2024 Mar 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

Record details

×
Academic Journal

[Is "tobacco harm reduction" possible? Other countries' experiences and perspectives, and how they could inform tobacco control in Japan].

  • Authors : Katanoda K; Division of Population Data Science, National Cancer Center Institute for Cancer Control.; Togawa K

Subjects: Harm Reduction* ; Tobacco Control*; Humans

  • Source: [Nihon koshu eisei zasshi] Japanese journal of public health [Nihon Koshu Eisei Zasshi] 2024 Mar 19; Vol. 71 (3), pp. 141-152. Date of Electronic Publication: 2023 Dec 21.Publisher: Nippon Kōshū Eisei Kyōkai Country of Publication: Japan NLM ID: 19130150R Publication Model: Print-Electronic

Record details

×
  • 1-10 of  479,803 results for ""UNITED States""